The European Commission has awarded the prestigious EU Mission Label to 39 additional cities as part of the EU Mission for Climate-Neutral and Smart Cities.
Artificial intelligence and digital transformation play an important role in improving cancer diagnosis, treatments and increasing cancer survival rates, writes Dee Mathieson, Senior Vice President Linac Service and Managing Director of Elekta Ltd.
A new study estimates HIV disproportionately affects trans feminine women, with 20% of trans feminine individuals being positive with the virus, highlighting the need for prevention efforts and appropriate sex education.
Chaith Kondragunta, CEO at AIRA Matrix Private Limited, details Artificial Intelligence-based solutions that can positively impact prostate cancer outcomes.
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, sheds light on food allergies and considers if this is an epidemic
Kristoffer Böttzauw, Director General, Danish Energy Agency, explores the impact of green heating in a clean, liveable city
If you take a stroll in the...
A new study on HIV medication treatment discovered persistent disparities between sex and age, potentially subjecting women to worse HIV treatment outcomes on the drug dolutegravir.
Dr Carlos Ziebert, Head of IAM-AWP’s Calorimeter Center, KIT, explains how venting gases of batteries can be collected and analysed
In addition to the achievable...
Elin Eriksen Ødegaard, Director and Professor in Early Childhood Pedagogy, Western Norway University of Applied Sciences, discusses why grounding ecological lifestyles and ‘glocal’ mentalities in early years is key to sustainability education.
Professor at the University of Padova, explains what we need to know about taming the environmental impact of mobile networks through GREENEDGE computing
Dianne Morrison-Beedy, PhD, RN, FNAP, FAANP, FAAN and Bernadette Melnyk, PhD, APRN-CNP, FNAP, FAANP, FAAN, issue an urgent call to action when it comes to combatting sexual risk-taking and mental health issues in adolescent females.
Dr Hernando Lopez-Bertoni at the Department of Neurology, Johns Hopkins School of medicine, discusses the development of miRNAs in brain cancer therapy
